PD-L1 expression in cell-blocks of non-small cell lung cancer: The impact of prolonged fixation

Diagn Cytopathol. 2020 Jul;48(7):595-603. doi: 10.1002/dc.24439. Epub 2020 Apr 25.

Abstract

Introduction: In the selection of non-small cell lung cancer (NSCLC) patients for immunotherapy, specimen processed as cell blocks (CBs) may be the only available material to assess PD-L1 expression. Therefore, optimal CB preparation becomes paramount. In this context, here we assessed whether inadequate fixation time might be one of the pre-analytical factors affecting PD-L1 expression.

Methods: Ex vivo CBs from placental (n = 3) and NSCLC (n = 8) resection specimens were obtained. PD-L1 staining was performed on CBs prepared at increasing fixation times (12 hours, 48 hours, 72 hours, 96 hours, 168 hours and 504 hours) using the companion diagnostic SP263 Assay and a validated 22C3 laboratory developed test (LDT). Staining intensity and percentage of positive cells were evaluated.

Results: All placental CBs showed moderate to strong PD-L1 positivity in most cells, regardless of the fixation time. Likewise, the percentage of SP263-stained NSCLC cells was similar at all fixation times except for one case, which showed less intense SP263 staining at 168 hours. Conversely, in 5/8 cases, the 22C3 LDT percentage of positive cells and staining intensity decreased at 168 hours and 504 hours.

Conclusions: Our results show that fixation time influences the performance of 22C3 LDT on CBs. Thus, we recommend that the fixation time of cytological materials be carefully checked, especially when PD-L1 testing is delayed until the oncology request. Indeed, delays in tissue processing and paraffin embedding may lead to sub-optimal performance of PD-L1 staining on CBs.

Keywords: PD-L1; cell block; fixation; immunotherapy; lung cancer; pre-analytical.

MeSH terms

  • B7-H1 Antigen / analysis*
  • Biomarkers, Tumor / analysis*
  • Carcinoma, Non-Small-Cell Lung / diagnosis*
  • Cytodiagnosis / methods
  • Humans
  • Immunohistochemistry / methods
  • Lung Neoplasms / diagnosis*
  • Tissue Fixation*

Substances

  • B7-H1 Antigen
  • Biomarkers, Tumor
  • CD274 protein, human